Hair thinning (telogen effluvium) is related to rapid weight loss and caloric deficit, not directly to the drug dose
Metsera reports positive phase 2b results for first- and best-in-class ultra-long acting GLP-1 RA candidate MET-097i, enabling rapid transition into phase 3
Louis: Clinically Proven Results: Studies have shown that Semaglutide patients can lose up to 15% of their body weight
So, if you are reading this and you are not a victim, imagine the hunger pangs that prompt you to nourish your body, only to be met with pain, nausea, and vomiting every time you try to eat
In case a pregnant patient has already exposed themselves to Semaglutide, she must register herself to the pregnancy exposure registry Novo Nordisk
it is a practical risk-reduction measure